All In MedTech

Company

Medicrea

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$22.0M

1 Form D offering, 2016 to 2016

Equity

$0

Stock sold for cash

Debt and convertible notes

$22.0M

$22.0M of it convertible

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: convertible note, $22.0M raised of $22.0M sought, first sale Aug 12, 2016, 12 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Aug 12, 2016Convertible note$22.0M$22.0M12Rule 506(b)Agent: Raymond JamesCommissions $1.3MForm D ↗Aug 26, 2016

Company details

From the company's latest Form D.

Legal name
MEDICREA
Headquarters
Neyron, France
Incorporated
France over five years before filing
Entity type
Corporation
Revenue range
$25,000,001 - $100,000,000
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    4 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Medicrea.

    Latest FDA decisions

    The 8 newest of 37 since 2015.

    Search the Clearance Tracker

    36 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    10 more trials with a free account

    Reports received

    46

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    41

    89% of reports

    Injury reports

    5

    11% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230400
    Jan 240200
    Feb 240000
    Mar 240000
    Apr 240200
    May 244100
    Jun 242200
    Jul 243000
    Aug 240000
    Sep 242000
    Oct 240200
    Nov 241000
    Dec 2416100
    Jan 257000
    Feb 252100
    Mar 254100
    Apr 251000
    May 251000
    Jun 251000
    Jul 252000
    Aug 250000
    Sep 253000
    Oct 252000
    Nov 2510000
    Dec 253000
    Jan 262000
    Feb 263000
    Mar 260000
    Apr 260000
    May 263400
    Jun 2616100
    Jul 260000
    Aug 261000
    Sep 261000
    Oct 262000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    3 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    4 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    21 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.